Raymond James & Associates VALEANT PHARMACEUTICALS INTL Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
N/A
-150,245 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
N/A
60,944 Added 68.25%
150,245 $3.49 Million
Q1 2018

May 14, 2018
BUY
N/A
13,860 Added 18.37%
89,301 $1.42 Million
Q4 2017

Feb 14, 2018
SELL
N/A
-123,819 Reduced 62.14%
75,441 $1.57 Million
Q3 2017

Nov 13, 2017
SELL
N/A
-11,917 Reduced 5.64%
199,260 $2.86 Million
Q2 2017

Aug 14, 2017
BUY
N/A
211,177
211,177 $3.65 Million
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email